nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Haematochezia—Mesalazine—Crohn's disease	0.0222	0.0378	CcSEcCtD
Remifentanil—Pericarditis—Mesalazine—Crohn's disease	0.0207	0.0352	CcSEcCtD
Remifentanil—Ache—Mesalazine—Crohn's disease	0.0194	0.033	CcSEcCtD
Remifentanil—Pleural effusion—Mesalazine—Crohn's disease	0.0117	0.0199	CcSEcCtD
Remifentanil—OPRD1—Peptide GPCRs—CCR9—Crohn's disease	0.0113	0.028	CbGpPWpGaD
Remifentanil—Rhinorrhoea—Mesalazine—Crohn's disease	0.011	0.0188	CcSEcCtD
Remifentanil—Musculoskeletal stiffness—Mesalazine—Crohn's disease	0.00998	0.017	CcSEcCtD
Remifentanil—OPRK1—Peptide GPCRs—CCR9—Crohn's disease	0.00992	0.0246	CbGpPWpGaD
Remifentanil—Leukocytosis—Mesalazine—Crohn's disease	0.00952	0.0162	CcSEcCtD
Remifentanil—Lymphopenia—Prednisone—Crohn's disease	0.00925	0.0158	CcSEcCtD
Remifentanil—OPRM1—Peptide GPCRs—CCR9—Crohn's disease	0.00839	0.0208	CbGpPWpGaD
Remifentanil—Hepatic function abnormal—Azathioprine—Crohn's disease	0.00816	0.0139	CcSEcCtD
Remifentanil—OPRD1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.0081	0.0201	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.00768	0.019	CbGpPWpGaD
Remifentanil—OPRD1—Peptide GPCRs—CCR6—Crohn's disease	0.0075	0.0186	CbGpPWpGaD
Remifentanil—Immune system disorder—Mercaptopurine—Crohn's disease	0.00748	0.0127	CcSEcCtD
Remifentanil—Disorientation—Mesalazine—Crohn's disease	0.00726	0.0124	CcSEcCtD
Remifentanil—OPRK1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.0071	0.0176	CbGpPWpGaD
Remifentanil—Atrial fibrillation—Mesalazine—Crohn's disease	0.00686	0.0117	CcSEcCtD
Remifentanil—Renal impairment—Mesalazine—Crohn's disease	0.00683	0.0116	CcSEcCtD
Remifentanil—OPRK1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.00673	0.0167	CbGpPWpGaD
Remifentanil—Anaemia—Mercaptopurine—Crohn's disease	0.00666	0.0113	CcSEcCtD
Remifentanil—OPRK1—Peptide GPCRs—CCR6—Crohn's disease	0.00657	0.0163	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00634	0.0157	CbGpPWpGaD
Remifentanil—Alfentanil—ALB—Crohn's disease	0.00633	0.689	CrCbGaD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.0061	0.0104	CcSEcCtD
Remifentanil—OPRM1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.006	0.0149	CbGpPWpGaD
Remifentanil—Abdominal discomfort—Azathioprine—Crohn's disease	0.00591	0.0101	CcSEcCtD
Remifentanil—Oedema—Mercaptopurine—Crohn's disease	0.00588	0.01	CcSEcCtD
Remifentanil—Nasopharyngitis—Mesalazine—Crohn's disease	0.00581	0.00989	CcSEcCtD
Remifentanil—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00576	0.00981	CcSEcCtD
Remifentanil—Skin disorder—Mercaptopurine—Crohn's disease	0.00571	0.00973	CcSEcCtD
Remifentanil—OPRM1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.00569	0.0141	CbGpPWpGaD
Remifentanil—Dysphagia—Mesalazine—Crohn's disease	0.00562	0.00956	CcSEcCtD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00556	0.0138	CbGpPWpGaD
Remifentanil—OPRM1—Peptide GPCRs—CCR6—Crohn's disease	0.00556	0.0138	CbGpPWpGaD
Remifentanil—Pneumonia—Azathioprine—Crohn's disease	0.00553	0.00941	CcSEcCtD
Remifentanil—Bronchospasm—Mesalazine—Crohn's disease	0.00552	0.00941	CcSEcCtD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00543	0.0135	CbGpPWpGaD
Remifentanil—Bronchitis—Mesalazine—Crohn's disease	0.0054	0.0092	CcSEcCtD
Remifentanil—Abdominal discomfort—Mesalazine—Crohn's disease	0.00538	0.00917	CcSEcCtD
Remifentanil—OPRD1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.00532	0.0132	CbGpPWpGaD
Remifentanil—Dysuria—Mesalazine—Crohn's disease	0.00525	0.00894	CcSEcCtD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00515	0.0128	CbGpPWpGaD
Remifentanil—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00508	0.00865	CcSEcCtD
Remifentanil—Leukocytosis—Prednisone—Crohn's disease	0.00504	0.00858	CcSEcCtD
Remifentanil—Pneumonia—Mesalazine—Crohn's disease	0.00504	0.00858	CcSEcCtD
Remifentanil—Haemoglobin—Azathioprine—Crohn's disease	0.00496	0.00845	CcSEcCtD
Remifentanil—Haemorrhage—Azathioprine—Crohn's disease	0.00493	0.0084	CcSEcCtD
Remifentanil—Renal failure—Mesalazine—Crohn's disease	0.00492	0.00838	CcSEcCtD
Remifentanil—Sweating—Mesalazine—Crohn's disease	0.0048	0.00817	CcSEcCtD
Remifentanil—Haematuria—Mesalazine—Crohn's disease	0.00477	0.00813	CcSEcCtD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00476	0.0118	CbGpPWpGaD
Remifentanil—Hiccups—Prednisone—Crohn's disease	0.00474	0.00806	CcSEcCtD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.0047	0.0116	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.00467	0.0116	CbGpPWpGaD
Remifentanil—Body temperature increased—Mercaptopurine—Crohn's disease	0.00465	0.00792	CcSEcCtD
Remifentanil—Haemoglobin—Mesalazine—Crohn's disease	0.00452	0.00769	CcSEcCtD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00452	0.0112	CbGpPWpGaD
Remifentanil—Haemorrhage—Mesalazine—Crohn's disease	0.00449	0.00765	CcSEcCtD
Remifentanil—OPRD1—G alpha (i) signalling events—CCR9—Crohn's disease	0.00449	0.0111	CbGpPWpGaD
Remifentanil—Pharyngitis—Mesalazine—Crohn's disease	0.00446	0.0076	CcSEcCtD
Remifentanil—Immune system disorder—Azathioprine—Crohn's disease	0.00446	0.00759	CcSEcCtD
Remifentanil—Mediastinal disorder—Azathioprine—Crohn's disease	0.00445	0.00757	CcSEcCtD
Remifentanil—Chills—Azathioprine—Crohn's disease	0.00443	0.00754	CcSEcCtD
Remifentanil—Arrhythmia—Azathioprine—Crohn's disease	0.00441	0.00751	CcSEcCtD
Remifentanil—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00433	0.00738	CcSEcCtD
Remifentanil—Pulmonary oedema—Prednisone—Crohn's disease	0.00421	0.00718	CcSEcCtD
Remifentanil—OPRM1—IL4-mediated signaling events—SOCS1—Crohn's disease	0.00421	0.0104	CbGpPWpGaD
Remifentanil—Cardiac disorder—Mesalazine—Crohn's disease	0.00417	0.0071	CcSEcCtD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00417	0.0103	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—ACKR2—Crohn's disease	0.00414	0.0102	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—IL17A—Crohn's disease	0.00412	0.0102	CbGpPWpGaD
Remifentanil—Angiopathy—Mesalazine—Crohn's disease	0.00408	0.00694	CcSEcCtD
Remifentanil—Immune system disorder—Mesalazine—Crohn's disease	0.00406	0.00691	CcSEcCtD
Remifentanil—Mediastinal disorder—Mesalazine—Crohn's disease	0.00405	0.0069	CcSEcCtD
Remifentanil—Chills—Mesalazine—Crohn's disease	0.00403	0.00687	CcSEcCtD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00403	0.00998	CbGpPWpGaD
Remifentanil—Diarrhoea—Mercaptopurine—Crohn's disease	0.00403	0.00686	CcSEcCtD
Remifentanil—Anaemia—Azathioprine—Crohn's disease	0.00397	0.00676	CcSEcCtD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.00394	0.00977	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CCR9—Crohn's disease	0.00394	0.00975	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—MLN—Crohn's disease	0.00392	0.00972	CbGpPWpGaD
Remifentanil—Erythema—Mesalazine—Crohn's disease	0.00391	0.00666	CcSEcCtD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00387	0.0096	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00382	0.00946	CbGpPWpGaD
Remifentanil—OPRM1—IL4-mediated signaling events—IL10—Crohn's disease	0.00377	0.00935	CbGpPWpGaD
Remifentanil—Vomiting—Mercaptopurine—Crohn's disease	0.00374	0.00637	CcSEcCtD
Remifentanil—Rash—Mercaptopurine—Crohn's disease	0.00371	0.00632	CcSEcCtD
Remifentanil—Dermatitis—Mercaptopurine—Crohn's disease	0.00371	0.00631	CcSEcCtD
Remifentanil—Tremor—Mesalazine—Crohn's disease	0.00367	0.00624	CcSEcCtD
Remifentanil—Amnesia—Prednisone—Crohn's disease	0.00366	0.00623	CcSEcCtD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00365	0.00905	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—RIPK2—Crohn's disease	0.00365	0.00905	CbGpPWpGaD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00363	0.00618	CcSEcCtD
Remifentanil—OPRK1—GPCR ligand binding—ACKR2—Crohn's disease	0.00363	0.00899	CbGpPWpGaD
Remifentanil—Anaemia—Mesalazine—Crohn's disease	0.00362	0.00616	CcSEcCtD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00357	0.00884	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00353	0.00873	CbGpPWpGaD
Remifentanil—Syncope—Mesalazine—Crohn's disease	0.00351	0.00598	CcSEcCtD
Remifentanil—Nausea—Mercaptopurine—Crohn's disease	0.00349	0.00595	CcSEcCtD
Remifentanil—OPRK1—GPCR ligand binding—MLN—Crohn's disease	0.00344	0.00852	CbGpPWpGaD
Remifentanil—Loss of consciousness—Mesalazine—Crohn's disease	0.00344	0.00586	CcSEcCtD
Remifentanil—Thrombocytopenia—Azathioprine—Crohn's disease	0.00343	0.00585	CcSEcCtD
Remifentanil—Cough—Mesalazine—Crohn's disease	0.00341	0.00581	CcSEcCtD
Remifentanil—Skin disorder—Azathioprine—Crohn's disease	0.00341	0.0058	CcSEcCtD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.0034	0.00842	CbGpPWpGaD
Remifentanil—Hypertension—Mesalazine—Crohn's disease	0.00338	0.00575	CcSEcCtD
Remifentanil—OPRM1—G alpha (i) signalling events—CCR9—Crohn's disease	0.00333	0.00824	CbGpPWpGaD
Remifentanil—Anxiety—Mesalazine—Crohn's disease	0.00332	0.00565	CcSEcCtD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00332	0.00822	CbGpPWpGaD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00331	0.00563	CcSEcCtD
Remifentanil—Hypotension—Azathioprine—Crohn's disease	0.00328	0.00558	CcSEcCtD
Remifentanil—Cardiac arrest—Prednisone—Crohn's disease	0.00327	0.00557	CcSEcCtD
Remifentanil—Dry mouth—Mesalazine—Crohn's disease	0.00326	0.00555	CcSEcCtD
Remifentanil—Confusional state—Mesalazine—Crohn's disease	0.00322	0.00548	CcSEcCtD
Remifentanil—Anaphylactic shock—Mesalazine—Crohn's disease	0.00319	0.00544	CcSEcCtD
Remifentanil—Oedema—Mesalazine—Crohn's disease	0.00319	0.00544	CcSEcCtD
Remifentanil—Shock—Mesalazine—Crohn's disease	0.00314	0.00535	CcSEcCtD
Remifentanil—Nervous system disorder—Mesalazine—Crohn's disease	0.00313	0.00533	CcSEcCtD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00313	0.00776	CbGpPWpGaD
Remifentanil—Hypokalaemia—Prednisone—Crohn's disease	0.00313	0.00533	CcSEcCtD
Remifentanil—Thrombocytopenia—Mesalazine—Crohn's disease	0.00313	0.00532	CcSEcCtD
Remifentanil—Tachycardia—Mesalazine—Crohn's disease	0.00312	0.00531	CcSEcCtD
Remifentanil—Skin disorder—Mesalazine—Crohn's disease	0.0031	0.00528	CcSEcCtD
Remifentanil—OPRK1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00309	0.00766	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00309	0.00765	CbGpPWpGaD
Remifentanil—Hyperhidrosis—Mesalazine—Crohn's disease	0.00309	0.00526	CcSEcCtD
Remifentanil—OPRM1—GPCR ligand binding—ACKR2—Crohn's disease	0.00307	0.0076	CbGpPWpGaD
Remifentanil—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00303	0.00515	CcSEcCtD
Remifentanil—Hypotension—Mesalazine—Crohn's disease	0.00298	0.00508	CcSEcCtD
Remifentanil—OPRD1—G alpha (i) signalling events—CCR6—Crohn's disease	0.00297	0.00737	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00291	0.00721	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—MLN—Crohn's disease	0.00291	0.0072	CbGpPWpGaD
Remifentanil—Feeling abnormal—Azathioprine—Crohn's disease	0.00289	0.00492	CcSEcCtD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00287	0.00711	CbGpPWpGaD
Remifentanil—Paraesthesia—Mesalazine—Crohn's disease	0.00287	0.00488	CcSEcCtD
Remifentanil—Pethidine—ALB—Crohn's disease	0.00285	0.311	CrCbGaD
Remifentanil—Dyspnoea—Mesalazine—Crohn's disease	0.00285	0.00485	CcSEcCtD
Remifentanil—Somnolence—Mesalazine—Crohn's disease	0.00284	0.00483	CcSEcCtD
Remifentanil—Dyspepsia—Mesalazine—Crohn's disease	0.00281	0.00479	CcSEcCtD
Remifentanil—Body temperature increased—Azathioprine—Crohn's disease	0.00277	0.00472	CcSEcCtD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00276	0.00684	CbGpPWpGaD
Remifentanil—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00276	0.00469	CcSEcCtD
Remifentanil—Constipation—Mesalazine—Crohn's disease	0.00273	0.00465	CcSEcCtD
Remifentanil—Pain—Mesalazine—Crohn's disease	0.00273	0.00465	CcSEcCtD
Remifentanil—OPRD1—GPCR ligand binding—CCR9—Crohn's disease	0.00272	0.00674	CbGpPWpGaD
Remifentanil—Hyperglycaemia—Prednisone—Crohn's disease	0.00268	0.00456	CcSEcCtD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00265	0.00655	CbGpPWpGaD
Remifentanil—Feeling abnormal—Mesalazine—Crohn's disease	0.00263	0.00448	CcSEcCtD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00261	0.00647	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CCR6—Crohn's disease	0.00261	0.00646	CbGpPWpGaD
Remifentanil—Hypersensitivity—Azathioprine—Crohn's disease	0.00258	0.0044	CcSEcCtD
Remifentanil—Urticaria—Mesalazine—Crohn's disease	0.00254	0.00432	CcSEcCtD
Remifentanil—OPRD1—GPCR ligand binding—GPR65—Crohn's disease	0.00253	0.00626	CbGpPWpGaD
Remifentanil—Body temperature increased—Mesalazine—Crohn's disease	0.00252	0.0043	CcSEcCtD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00246	0.00609	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00243	0.00602	CbGpPWpGaD
Remifentanil—Bradycardia—Prednisone—Crohn's disease	0.00242	0.00412	CcSEcCtD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00242	0.006	CbGpPWpGaD
Remifentanil—Diarrhoea—Azathioprine—Crohn's disease	0.0024	0.00408	CcSEcCtD
Remifentanil—Haemoglobin—Prednisone—Crohn's disease	0.00239	0.00407	CcSEcCtD
Remifentanil—OPRK1—GPCR ligand binding—CCR9—Crohn's disease	0.00238	0.00591	CbGpPWpGaD
Remifentanil—Haemorrhage—Prednisone—Crohn's disease	0.00238	0.00405	CcSEcCtD
Remifentanil—Hallucination—Prednisone—Crohn's disease	0.00237	0.00403	CcSEcCtD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00236	0.00586	CbGpPWpGaD
Remifentanil—Hypersensitivity—Mesalazine—Crohn's disease	0.00235	0.00401	CcSEcCtD
Remifentanil—Dizziness—Azathioprine—Crohn's disease	0.00232	0.00395	CcSEcCtD
Remifentanil—OPRM1—IL4-mediated signaling events—JAK2—Crohn's disease	0.00226	0.0056	CbGpPWpGaD
Remifentanil—Pruritus—Mesalazine—Crohn's disease	0.00226	0.00385	CcSEcCtD
Remifentanil—Vomiting—Azathioprine—Crohn's disease	0.00223	0.0038	CcSEcCtD
Remifentanil—OPRD1—GPCR downstream signaling—MLN—Crohn's disease	0.00222	0.00549	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—GPR65—Crohn's disease	0.00222	0.00549	CbGpPWpGaD
Remifentanil—Rash—Azathioprine—Crohn's disease	0.00221	0.00376	CcSEcCtD
Remifentanil—Dermatitis—Azathioprine—Crohn's disease	0.00221	0.00376	CcSEcCtD
Remifentanil—Flushing—Prednisone—Crohn's disease	0.00221	0.00376	CcSEcCtD
Remifentanil—OPRM1—G alpha (i) signalling events—CCR6—Crohn's disease	0.0022	0.00546	CbGpPWpGaD
Remifentanil—Headache—Azathioprine—Crohn's disease	0.0022	0.00374	CcSEcCtD
Remifentanil—Diarrhoea—Mesalazine—Crohn's disease	0.00218	0.00372	CcSEcCtD
Remifentanil—Angiopathy—Prednisone—Crohn's disease	0.00216	0.00367	CcSEcCtD
Remifentanil—Immune system disorder—Prednisone—Crohn's disease	0.00215	0.00366	CcSEcCtD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00213	0.00528	CbGpPWpGaD
Remifentanil—Arrhythmia—Prednisone—Crohn's disease	0.00212	0.00362	CcSEcCtD
Remifentanil—OPRD1—Signaling by GPCR—ACKR2—Crohn's disease	0.00212	0.00526	CbGpPWpGaD
Remifentanil—Dizziness—Mesalazine—Crohn's disease	0.00211	0.0036	CcSEcCtD
Remifentanil—Nausea—Azathioprine—Crohn's disease	0.00208	0.00355	CcSEcCtD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00208	0.00516	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00207	0.00514	CbGpPWpGaD
Remifentanil—Erythema—Prednisone—Crohn's disease	0.00207	0.00353	CcSEcCtD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00205	0.00507	CbGpPWpGaD
Remifentanil—Vomiting—Mesalazine—Crohn's disease	0.00203	0.00346	CcSEcCtD
Remifentanil—OPRM1—GPCR ligand binding—CCR9—Crohn's disease	0.00201	0.00499	CbGpPWpGaD
Remifentanil—Rash—Mesalazine—Crohn's disease	0.00201	0.00343	CcSEcCtD
Remifentanil—OPRD1—Signaling by GPCR—MLN—Crohn's disease	0.00201	0.00499	CbGpPWpGaD
Remifentanil—Dermatitis—Mesalazine—Crohn's disease	0.00201	0.00343	CcSEcCtD
Remifentanil—Headache—Mesalazine—Crohn's disease	0.002	0.00341	CcSEcCtD
Remifentanil—OPRK1—GPCR downstream signaling—MLN—Crohn's disease	0.00194	0.00482	CbGpPWpGaD
Remifentanil—Anaemia—Prednisone—Crohn's disease	0.00191	0.00326	CcSEcCtD
Remifentanil—Agitation—Prednisone—Crohn's disease	0.0019	0.00324	CcSEcCtD
Remifentanil—Nausea—Mesalazine—Crohn's disease	0.0019	0.00323	CcSEcCtD
Remifentanil—OPRM1—GPCR ligand binding—GPR65—Crohn's disease	0.00187	0.00464	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—ACKR2—Crohn's disease	0.00186	0.00461	CbGpPWpGaD
Remifentanil—Syncope—Prednisone—Crohn's disease	0.00186	0.00316	CcSEcCtD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00183	0.00452	CbGpPWpGaD
Remifentanil—Loss of consciousness—Prednisone—Crohn's disease	0.00182	0.0031	CcSEcCtD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.0018	0.00446	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CCR6—Crohn's disease	0.0018	0.00446	CbGpPWpGaD
Remifentanil—Convulsion—Prednisone—Crohn's disease	0.00179	0.00305	CcSEcCtD
Remifentanil—Hypertension—Prednisone—Crohn's disease	0.00179	0.00304	CcSEcCtD
Remifentanil—OPRK1—Signaling by GPCR—MLN—Crohn's disease	0.00176	0.00437	CbGpPWpGaD
Remifentanil—Anxiety—Prednisone—Crohn's disease	0.00176	0.00299	CcSEcCtD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00175	0.00434	CbGpPWpGaD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00175	0.00298	CcSEcCtD
Remifentanil—Oedema—Prednisone—Crohn's disease	0.00169	0.00288	CcSEcCtD
Remifentanil—Anaphylactic shock—Prednisone—Crohn's disease	0.00169	0.00288	CcSEcCtD
Remifentanil—Shock—Prednisone—Crohn's disease	0.00166	0.00283	CcSEcCtD
Remifentanil—Nervous system disorder—Prednisone—Crohn's disease	0.00166	0.00282	CcSEcCtD
Remifentanil—Tachycardia—Prednisone—Crohn's disease	0.00165	0.00281	CcSEcCtD
Remifentanil—OPRM1—GPCR downstream signaling—MLN—Crohn's disease	0.00164	0.00407	CbGpPWpGaD
Remifentanil—Skin disorder—Prednisone—Crohn's disease	0.00164	0.00279	CcSEcCtD
Remifentanil—Hyperhidrosis—Prednisone—Crohn's disease	0.00163	0.00278	CcSEcCtD
Remifentanil—OPRM1—TCR Signaling Pathway—CD4—Crohn's disease	0.00159	0.00394	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—PTGER4—Crohn's disease	0.00159	0.00393	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CCR6—Crohn's disease	0.00158	0.00391	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—ACKR2—Crohn's disease	0.00157	0.0039	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00154	0.00382	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CCR9—Crohn's disease	0.00154	0.00381	CbGpPWpGaD
Remifentanil—Paraesthesia—Prednisone—Crohn's disease	0.00152	0.00258	CcSEcCtD
Remifentanil—OPRM1—Signaling by GPCR—MLN—Crohn's disease	0.00149	0.0037	CbGpPWpGaD
Remifentanil—Dyspepsia—Prednisone—Crohn's disease	0.00149	0.00253	CcSEcCtD
Remifentanil—OPRM1—TCR Signaling Pathway—IL1B—Crohn's disease	0.00147	0.00364	CbGpPWpGaD
Remifentanil—Constipation—Prednisone—Crohn's disease	0.00144	0.00246	CcSEcCtD
Remifentanil—OPRD1—GPCR downstream signaling—GPR65—Crohn's disease	0.00143	0.00354	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCR9—Crohn's disease	0.0014	0.00346	CbGpPWpGaD
Remifentanil—Feeling abnormal—Prednisone—Crohn's disease	0.00139	0.00237	CcSEcCtD
Remifentanil—OPRK1—GPCR ligand binding—PTGER4—Crohn's disease	0.00139	0.00344	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CCR9—Crohn's disease	0.00135	0.00334	CbGpPWpGaD
Remifentanil—Urticaria—Prednisone—Crohn's disease	0.00134	0.00229	CcSEcCtD
Remifentanil—Body temperature increased—Prednisone—Crohn's disease	0.00134	0.00227	CcSEcCtD
Remifentanil—OPRM1—GPCR ligand binding—CCR6—Crohn's disease	0.00133	0.00331	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—GPR65—Crohn's disease	0.0013	0.00321	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ACKR2—Crohn's disease	0.00125	0.00311	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—GPR65—Crohn's disease	0.00125	0.0031	CbGpPWpGaD
Remifentanil—Hypersensitivity—Prednisone—Crohn's disease	0.00124	0.00212	CcSEcCtD
Remifentanil—OPRK1—Signaling by GPCR—CCR9—Crohn's disease	0.00122	0.00303	CbGpPWpGaD
Remifentanil—Pruritus—Prednisone—Crohn's disease	0.0012	0.00204	CcSEcCtD
Remifentanil—OPRD1—Signaling Pathways—MLN—Crohn's disease	0.00119	0.00295	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—PTGER4—Crohn's disease	0.00117	0.00291	CbGpPWpGaD
Remifentanil—Diarrhoea—Prednisone—Crohn's disease	0.00116	0.00197	CcSEcCtD
Remifentanil—OPRM1—GPCR downstream signaling—CCR9—Crohn's disease	0.00114	0.00282	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—GPR65—Crohn's disease	0.00114	0.00282	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.00114	0.00281	CbGpPWpGaD
Remifentanil—Dizziness—Prednisone—Crohn's disease	0.00112	0.0019	CcSEcCtD
Remifentanil—OPRK1—Signaling Pathways—ACKR2—Crohn's disease	0.0011	0.00272	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TAGAP—Crohn's disease	0.00109	0.00269	CbGpPWpGaD
Remifentanil—Vomiting—Prednisone—Crohn's disease	0.00107	0.00183	CcSEcCtD
Remifentanil—Rash—Prednisone—Crohn's disease	0.00107	0.00181	CcSEcCtD
Remifentanil—Dermatitis—Prednisone—Crohn's disease	0.00106	0.00181	CcSEcCtD
Remifentanil—OPRM1—GPCR downstream signaling—GPR65—Crohn's disease	0.00106	0.00262	CbGpPWpGaD
Remifentanil—Headache—Prednisone—Crohn's disease	0.00106	0.0018	CcSEcCtD
Remifentanil—OPRK1—Signaling Pathways—MLN—Crohn's disease	0.00104	0.00258	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCR9—Crohn's disease	0.00103	0.00256	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CCR6—Crohn's disease	0.00102	0.00252	CbGpPWpGaD
Remifentanil—Nausea—Prednisone—Crohn's disease	0.001	0.00171	CcSEcCtD
Remifentanil—OPRK1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000996	0.00247	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—GPR65—Crohn's disease	0.000961	0.00238	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000958	0.00237	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TAGAP—Crohn's disease	0.000954	0.00236	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RSPO3—Crohn's disease	0.00095	0.00235	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ACKR2—Crohn's disease	0.000929	0.0023	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCR6—Crohn's disease	0.000924	0.00229	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SEL1L—Crohn's disease	0.000901	0.00223	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000896	0.00222	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CCR6—Crohn's disease	0.000892	0.00221	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MLN—Crohn's disease	0.000881	0.00218	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—IL6—Crohn's disease	0.00086	0.00213	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000842	0.00209	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00084	0.00208	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RSPO3—Crohn's disease	0.000833	0.00206	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCR9—Crohn's disease	0.000824	0.00204	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PTGER4—Crohn's disease	0.000814	0.00202	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCR6—Crohn's disease	0.00081	0.00201	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TAGAP—Crohn's disease	0.000806	0.002	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SEL1L—Crohn's disease	0.00079	0.00196	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000786	0.00195	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GPR65—Crohn's disease	0.000766	0.0019	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—IL3—Crohn's disease	0.000763	0.00189	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000762	0.00189	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CCR6—Crohn's disease	0.000754	0.00187	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000738	0.00183	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCR9—Crohn's disease	0.000723	0.00179	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PTGER4—Crohn's disease	0.000713	0.00177	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00071	0.00176	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RSPO3—Crohn's disease	0.000704	0.00175	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL3—Crohn's disease	0.000693	0.00172	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCR6—Crohn's disease	0.000685	0.0017	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GPR65—Crohn's disease	0.000672	0.00166	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—RASGRP1—Crohn's disease	0.00067	0.00166	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—IL3—Crohn's disease	0.000669	0.00166	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000668	0.00166	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SEL1L—Crohn's disease	0.000668	0.00165	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000664	0.00165	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000647	0.0016	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCR9—Crohn's disease	0.000611	0.00151	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL3—Crohn's disease	0.000608	0.00151	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PTGER4—Crohn's disease	0.000603	0.00149	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000588	0.00146	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CXCL8—Crohn's disease	0.00058	0.00144	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GPR65—Crohn's disease	0.000568	0.00141	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—IL3—Crohn's disease	0.000566	0.0014	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000565	0.0014	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000547	0.00136	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCR6—Crohn's disease	0.000546	0.00135	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000535	0.00132	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL3—Crohn's disease	0.000514	0.00127	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CXCL8—Crohn's disease	0.000509	0.00126	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000497	0.00123	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RBX1—Crohn's disease	0.000494	0.00122	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL2RA—Crohn's disease	0.000485	0.0012	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PTGER4—Crohn's disease	0.000481	0.00119	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCR6—Crohn's disease	0.000479	0.00119	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000469	0.00116	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RBX1—Crohn's disease	0.000433	0.00107	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—UBE2D1—Crohn's disease	0.000433	0.00107	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CXCL8—Crohn's disease	0.00043	0.00107	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL2RA—Crohn's disease	0.000426	0.00105	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PTGER4—Crohn's disease	0.000421	0.00104	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RIPK2—Crohn's disease	0.00042	0.00104	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL3—Crohn's disease	0.000409	0.00101	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCR6—Crohn's disease	0.000405	0.001	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000396	0.000982	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RASGRP1—Crohn's disease	0.000396	0.000981	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—UBE2D1—Crohn's disease	0.00038	0.000941	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RIPK2—Crohn's disease	0.000368	0.000912	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RBX1—Crohn's disease	0.000366	0.000906	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL2RA—Crohn's disease	0.00036	0.000891	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—JAK2—Crohn's disease	0.000359	0.00089	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL3—Crohn's disease	0.000359	0.000889	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SOCS1—Crohn's disease	0.000359	0.000889	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTGER4—Crohn's disease	0.000356	0.000882	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RASGRP1—Crohn's disease	0.000347	0.00086	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—TYK2—Crohn's disease	0.000342	0.000847	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000328	0.000812	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—JAK2—Crohn's disease	0.000326	0.000808	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—UBE2D1—Crohn's disease	0.000321	0.000795	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—JAK2—Crohn's disease	0.000315	0.000781	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SOCS1—Crohn's disease	0.000315	0.000779	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RIPK2—Crohn's disease	0.000311	0.000771	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SMAD3—Crohn's disease	0.00031	0.000767	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL3—Crohn's disease	0.000303	0.000752	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—TYK2—Crohn's disease	0.0003	0.000743	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CXCL8—Crohn's disease	0.000298	0.000738	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RASGRP1—Crohn's disease	0.000293	0.000727	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000288	0.000712	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL2RA—Crohn's disease	0.000287	0.00071	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—JAK2—Crohn's disease	0.000286	0.000709	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SMAD3—Crohn's disease	0.000272	0.000673	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—JAK2—Crohn's disease	0.000266	0.00066	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SOCS1—Crohn's disease	0.000266	0.000659	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CXCL8—Crohn's disease	0.000261	0.000647	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—TYK2—Crohn's disease	0.000253	0.000628	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL2RA—Crohn's disease	0.000251	0.000623	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000243	0.000602	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—JAK2—Crohn's disease	0.000242	0.000599	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SMAD3—Crohn's disease	0.00023	0.000569	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCL8—Crohn's disease	0.000221	0.000547	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL2RA—Crohn's disease	0.000213	0.000527	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TYK2—Crohn's disease	0.000202	0.000501	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—JAK2—Crohn's disease	0.000193	0.000478	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TYK2—Crohn's disease	0.000177	0.000439	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCL8—Crohn's disease	0.000176	0.000436	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—JAK2—Crohn's disease	0.000169	0.000419	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL6—Crohn's disease	0.000167	0.000414	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL8—Crohn's disease	0.000154	0.000382	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TYK2—Crohn's disease	0.00015	0.000371	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6—Crohn's disease	0.000147	0.000363	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—JAK2—Crohn's disease	0.000143	0.000354	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—STAT3—Crohn's disease	0.000141	0.000351	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL8—Crohn's disease	0.00013	0.000323	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—STAT3—Crohn's disease	0.000124	0.000307	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6—Crohn's disease	0.000124	0.000307	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STAT3—Crohn's disease	0.000105	0.00026	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6—Crohn's disease	9.88e-05	0.000245	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6—Crohn's disease	8.67e-05	0.000215	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6—Crohn's disease	7.32e-05	0.000181	CbGpPWpGaD
